Zai Lab Granted Expedited China Review for Brain Cancer Medical Device

Zai Lab
Published on: August 12, 2019
Author: Amy Liu

Shanghai’s Zai Lab announced its electric field treatment for cancer, Tumor Treating Fields, was designated an Innovative Medical Device in China, which accelerates the approval process. Zai in-licensed greater China rights to the product from Novocare last year, and launched the product in Hong Kong in December as a treatment for glioblastoma multiform under the name Optune. Optune uses electric fields tuned to specific frequencies to disrupt cancer cell division, inhibiting tumor growth and inducing cancer cell death. Source: China Biotoday

Biotechnology Genomics Life Science Medical Device